The purpose of this study is to see how well the injection of the radiation enhancer (JNJ-90301900) into your cancer before you receive chemoradiotherapy followed by immunotherapy compares to chemoradiotherapy alone followed by immunotherapy.
Thank you for your interest, but this study will start enrolling soon.
North Carolina (Statewide)
Ashley Weiner
Lineberger Comprehensive Cancer Center
Clinical or Medical
Interventional
Cancer (Lung)
24-1840
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
